ANNXAnnexon, Inc.

Nasdaq annexonbio.com


$ 4.86 $ 0.14 (2.96 %)    

Wednesday, 08-May-2024 15:59:55 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 4.87
$ 4.76
$ 0.00 x 0
$ 0.00 x 0
$ 4.61 - $ 4.92
$ 1.57 - $ 8.40
1,618,207
na
368.53M
$ 1.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-08-2023 03-31-2023 10-Q
5 03-06-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 09-08-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 annexon-to-present-data-of-additional-phas3-2-clinical-results-of-anx007-from-archer-trial-in-geographic-atrophy-including-further-analyses-of-visual-acuity-and-photoreceptor-preservation-at-arvo-2024-annual-meeting

Additional data from the Phase 2 ARCHER trial demonstrating protection of visual acuity and anatomical structure following ANX0...

 cantor-fitzgerald-reiterates-overweight-on-annexon

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.

 needham-reiterates-buy-on-annexon-maintains-16-price-target

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

 annexon-inc-entered-sales-agreement-relating-to-sale-of-shares-of-common-stock-may-offer-shares-of-common-stock-from-time-to-time-for-100m

- SEC Filing

 cantor-fitzgerald-reiterates-overweight-on-annexon

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.

 wells-fargo-maintains-overweight-on-annexon-maintains-12-price-target

Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and maintains $12 price target.

 jp-morgan-maintains-overweight-on-annexon-raises-price-target-to-13

JP Morgan analyst Anupam Rama maintains Annexon (NASDAQ:ANNX) with a Overweight and raises the price target from $11 to $13.

 b-of-a-securities-maintains-buy-on-annexon-raises-price-target-to-10

B of A Securities analyst Tazeen Ahmad maintains Annexon (NASDAQ:ANNX) with a Buy and raises the price target from $7 to $10.

 cintas-reports-upbeat-earnings-joins-paysign-noah-holdings-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

 hc-wainwright--co-maintains-buy-on-annexon-maintains-30-price-target

HC Wainwright & Co. analyst Andrew Fein maintains Annexon (NASDAQ:ANNX) with a Buy and maintains $30 price target.

 wells-fargo-maintains-overweight-on-annexon-raises-price-target-to-12

Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and raises the price target from $11 to ...

 needham-reiterates-buy-on-annexon-maintains-16-price-target

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

 annexon-q4-eps-036-beats-048-estimate

Annexon (NASDAQ:ANNX) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.48) by 25...

 why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

 worthington-steel-posts-upbeat-results-joins-summit-midstream-partners-fedex-and-other-big-stocks-moving-higher-on-friday

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

 why-clover-health-investments-shares-are-trading-higher-by-11-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION